Abemaciclib (Verzenio)

abemaciclib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Abemaciclib (Verzenio), covering 2019-07-12 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC) [Phase 1, Phase 2]